Provided by Tiger Fintech (Singapore) Pte. Ltd.

NEUROONE MEDICAL TECH

1.08
+0.06005.88%
Post-market: 1.080.00000.00%18:47 EDT
Volume:86.68K
Turnover:91.36K
Market Cap:33.33M
PE:-4.28
High:1.09
Open:1.02
Low:1.01
Close:1.02
Loading ...

Company Profile

Company Name:
NEUROONE MEDICAL TECH
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
17
Office Location:
7599 Anagram Drive,Eden Prairie,Minnesota,United States
Zip Code:
55344
Fax:
- -
Introduction:
NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

Directors

Name
Position
David Rosa
Director, Chief Executive Officer and President
Paul Buckman
Director and Chairman of the Board
Mark Christianson
Business Development Director, Medical Sales Liaison
Edward Andrle
Director
Jeffrey Mathiesen
Director

Shareholders

Name
Position
David Rosa
Director, Chief Executive Officer and President
Christopher Volker
Chief Operating Officer
Ronald McClurg
Chief Financial Officer
Steve Mertens
Chief Technology Officer